Weeks after Gilead Sciences Inc. got hit with a $200 million verdict in March for infringing Merck & Co.’s patents on a Hepatitis C medication, Fish & Richardson litigators turned the game around for their client.
Lead trial attorneys Juanita Brooks and Jonathan Singer, San Diego partners at the firm, which represented Gilead, persuaded U.S. District Judge Beth Labson Freeman to toss the verdict due to Merck’s “unclean hands.”
This content has been archived. It is available through our partners, LexisNexis® and Bloomberg Law.
To view this content, please continue to their sites.
Not a Lexis Subscriber?
Subscribe Now
Not a Bloomberg Law Subscriber?
Subscribe Now
LexisNexis® and Bloomberg Law are third party online distributors of the broad collection of current and archived versions of ALM's legal news publications. LexisNexis® and Bloomberg Law customers are able to access and use ALM's content, including content from the National Law Journal, The American Lawyer, Legaltech News, The New York Law Journal, and Corporate Counsel, as well as other sources of legal information.
For questions call 1-877-256-2472 or contact us at [email protected]
